Target intelligence / Profile preview

Unspecified oxidoreductase

Molecular classification
Enzyme, Oxidoreductase
01

Overview

Oxidoreductases (EC 1) are a large and diverse class of enzymes that catalyze oxidation-reduction (redox) reactions by transferring electrons from a donor (reductant) to an acceptor (oxidant) (UniProt, 2024). These enzymes play critical roles in essential biological processes, including cellular respiration, metabolism of amino acids and lipids, and the detoxification of xenobiotics (Wikipedia, 2024). The term 'Unspecified oxidoreductase' is typically used in bioinformatics and proteomics to describe a protein sequence that contains structural motifs characteristic of the oxidoreductase family but whose specific substrate or precise biological function has not yet been experimentally determined (EBI, 2024). In the context of drug discovery and pharmacology, a target must be a specific, well-defined molecular entity, such as HMG-CoA reductase or Cyclooxygenase-2, to allow for the design of selective inhibitors or activators (NIH, 2024). Because 'Unspecified oxidoreductase' refers to a broad functional category rather than a single protein, it is not considered a valid therapeutic target for drug development (ChEMBL, 2024). Consequently, there are no specific drugs, mechanisms of action, or biomarkers associated with this generic designation, and any attempt to target such a broad class would likely result in significant off-target toxicity (StatPearls, 2024).

Other names
Oxidoreductase (unspecified)EC 1.-.-.-Oxidoreductase class
02

Mechanism of action

Not applicable for a non-specific enzyme class.

03

Biological functions

Oxidation-reduction reactionsMetabolismElectron transfer
04

Disease associations

Metabolic disordersCancerOxidative stress
05

Safety considerations

Lack of target specificityPotential for off-target effects if broad-spectrum inhibitors are used

Beyond the preview

Go deeper on Unspecified oxidoreductase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unspecified oxidoreductase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call